Cargando…
The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine
Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COV...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867033/ https://www.ncbi.nlm.nih.gov/pubmed/36680135 http://dx.doi.org/10.3390/v15010095 |
_version_ | 1784876241666441216 |
---|---|
author | Xu, Jiayu Liu, Mingde Niu, Xiaoyu Hanson, Juliette Jung, Kwonil Ru, Peng Tu, Huolin Jones, Daniel M. Vlasova, Anastasia N. Saif, Linda J. Wang, Qiuhong |
author_facet | Xu, Jiayu Liu, Mingde Niu, Xiaoyu Hanson, Juliette Jung, Kwonil Ru, Peng Tu, Huolin Jones, Daniel M. Vlasova, Anastasia N. Saif, Linda J. Wang, Qiuhong |
author_sort | Xu, Jiayu |
collection | PubMed |
description | Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COVID-19 vaccines. We generated a temperature-sensitive (TS) SARS-CoV-2 mutant TS11 via cold-adaptation of the WA1 strain in Vero E6 cells. TS11 replicated at >4 Log(10)-higher titers at 32 °C than at 39 °C. TS11 has multiple mutations, including those in nsp3, a 12-amino acid-deletion spanning the furin cleavage site of the S protein and a 371-nucleotide-deletion spanning the ORF7b-ORF8 genes. We tested the pathogenicity and protective efficacy of TS11 against challenge with a heterologous virulent SARS-CoV-2 D614G strain 14B in Syrian hamsters. Hamsters were randomly assigned to mock immunization-challenge (Mock-C) and TS11 immunization-challenge (TS11-C) groups. Like the mock group, TS11-vaccinated hamsters did not show any clinical signs and continuously gained body weight. TS11 replicated well in the nasal cavity but poorly in the lungs and caused only mild lesions in the lungs. After challenge, hamsters in the Mock-C group lost weight. In contrast, the animals in the TS11-C group continued gaining weight. The virus titers in the nasal turbinates and lungs of the TS11-C group were significantly lower than those in the Mock-C group, confirming the protective effects of TS11 immunization of hamsters. Histopathological examination demonstrated that animals in the Mock-C group had severe pulmonary lesions and large amounts of viral antigens in the lungs post-challenge; however, the TS11-C group had minimal pathological changes and few viral antigen-positive cells. In summary, the TS11 mutant was attenuated and induced protection against disease after a heterologous SARS-CoV-2 challenge in Syrian hamsters. |
format | Online Article Text |
id | pubmed-9867033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98670332023-01-22 The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine Xu, Jiayu Liu, Mingde Niu, Xiaoyu Hanson, Juliette Jung, Kwonil Ru, Peng Tu, Huolin Jones, Daniel M. Vlasova, Anastasia N. Saif, Linda J. Wang, Qiuhong Viruses Article Live attenuated vaccines (LAVs) replicate in the respiratory/oral mucosa, mimic natural infection, and can induce mucosal and systemic immune responses to the full repertoire of SARS-CoV-2 structural/nonstructural proteins. Generally, LAVs produce broader and more durable protection than current COVID-19 vaccines. We generated a temperature-sensitive (TS) SARS-CoV-2 mutant TS11 via cold-adaptation of the WA1 strain in Vero E6 cells. TS11 replicated at >4 Log(10)-higher titers at 32 °C than at 39 °C. TS11 has multiple mutations, including those in nsp3, a 12-amino acid-deletion spanning the furin cleavage site of the S protein and a 371-nucleotide-deletion spanning the ORF7b-ORF8 genes. We tested the pathogenicity and protective efficacy of TS11 against challenge with a heterologous virulent SARS-CoV-2 D614G strain 14B in Syrian hamsters. Hamsters were randomly assigned to mock immunization-challenge (Mock-C) and TS11 immunization-challenge (TS11-C) groups. Like the mock group, TS11-vaccinated hamsters did not show any clinical signs and continuously gained body weight. TS11 replicated well in the nasal cavity but poorly in the lungs and caused only mild lesions in the lungs. After challenge, hamsters in the Mock-C group lost weight. In contrast, the animals in the TS11-C group continued gaining weight. The virus titers in the nasal turbinates and lungs of the TS11-C group were significantly lower than those in the Mock-C group, confirming the protective effects of TS11 immunization of hamsters. Histopathological examination demonstrated that animals in the Mock-C group had severe pulmonary lesions and large amounts of viral antigens in the lungs post-challenge; however, the TS11-C group had minimal pathological changes and few viral antigen-positive cells. In summary, the TS11 mutant was attenuated and induced protection against disease after a heterologous SARS-CoV-2 challenge in Syrian hamsters. MDPI 2022-12-29 /pmc/articles/PMC9867033/ /pubmed/36680135 http://dx.doi.org/10.3390/v15010095 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Xu, Jiayu Liu, Mingde Niu, Xiaoyu Hanson, Juliette Jung, Kwonil Ru, Peng Tu, Huolin Jones, Daniel M. Vlasova, Anastasia N. Saif, Linda J. Wang, Qiuhong The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title | The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title_full | The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title_fullStr | The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title_full_unstemmed | The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title_short | The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine |
title_sort | cold-adapted, temperature-sensitive sars-cov-2 strain ts11 is attenuated in syrian hamsters and a candidate attenuated vaccine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867033/ https://www.ncbi.nlm.nih.gov/pubmed/36680135 http://dx.doi.org/10.3390/v15010095 |
work_keys_str_mv | AT xujiayu thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT liumingde thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT niuxiaoyu thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT hansonjuliette thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT jungkwonil thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT rupeng thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT tuhuolin thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT jonesdanielm thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT vlasovaanastasian thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT saiflindaj thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT wangqiuhong thecoldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT xujiayu coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT liumingde coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT niuxiaoyu coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT hansonjuliette coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT jungkwonil coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT rupeng coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT tuhuolin coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT jonesdanielm coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT vlasovaanastasian coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT saiflindaj coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine AT wangqiuhong coldadaptedtemperaturesensitivesarscov2straints11isattenuatedinsyrianhamstersandacandidateattenuatedvaccine |